annual FCF:
-$307.94M-$184.64M(-149.76%)Summary
- As of today (May 29, 2025), RNA annual free cash flow is -$307.94 million, with the most recent change of -$184.64 million (-149.76%) on December 31, 2024.
- During the last 3 years, RNA annual FCF has fallen by -$209.38 million (-212.46%).
- RNA annual FCF is now -13755.70% below its all-time high of $2.25 million, reached on December 31, 2019.
Performance
RNA Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$128.58M-$24.80M(-23.89%)Summary
- As of today (May 29, 2025), RNA quarterly free cash flow is -$128.58 million, with the most recent change of -$24.80 million (-23.89%) on March 31, 2025.
- Over the past year, RNA quarterly FCF has dropped by -$57.29 million (-80.35%).
- RNA quarterly FCF is now -922.24% below its all-time high of $15.64 million, reached on December 31, 2023.
Performance
RNA quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$365.22M-$57.29M(-18.60%)Summary
- As of today (May 29, 2025), RNA TTM free cash flow is -$365.22 million, with the most recent change of -$57.29 million (-18.60%) on March 31, 2025.
- Over the past year, RNA TTM FCF has dropped by -$221.42 million (-153.98%).
- RNA TTM FCF is now -2853.49% below its all-time high of $13.26 million, reached on June 30, 2019.
Performance
RNA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
RNA Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -149.8% | -80.3% | -154.0% |
| 3 y3 years | -212.5% | -323.9% | -236.1% |
| 5 y5 years | -10000.0% | -1698.3% | -10000.0% |
RNA Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -212.5% | at low | -922.2% | at low | -236.1% | at low |
| 5 y | 5-year | <-9999.0% | at low | -922.2% | at low | <-9999.0% | at low |
| alltime | all time | <-9999.0% | at low | -922.2% | at low | -2853.5% | at low |
RNA Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$128.58M(+23.9%) | -$365.22M(+18.6%) |
| Dec 2024 | -$307.94M(+149.8%) | -$103.79M(+54.2%) | -$307.94M(+63.4%) |
| Sep 2024 | - | -$67.32M(+2.7%) | -$188.51M(+18.6%) |
| Jun 2024 | - | -$65.53M(-8.1%) | -$158.91M(+10.5%) |
| Mar 2024 | - | -$71.30M(-555.9%) | -$143.80M(+16.6%) |
| Dec 2023 | -$123.29M(-11.4%) | $15.64M(-141.5%) | -$123.29M(-31.1%) |
| Sep 2023 | - | -$37.71M(-25.2%) | -$178.97M(+3.4%) |
| Jun 2023 | - | -$50.43M(-0.7%) | -$173.11M(+8.5%) |
| Mar 2023 | - | -$50.79M(+26.8%) | -$159.55M(+14.7%) |
| Dec 2022 | -$139.09M(+41.1%) | -$40.04M(+25.7%) | -$139.09M(+9.5%) |
| Sep 2022 | - | -$31.85M(-13.6%) | -$126.97M(+8.8%) |
| Jun 2022 | - | -$36.87M(+21.5%) | -$116.70M(+7.4%) |
| Mar 2022 | - | -$30.33M(+8.6%) | -$108.68M(+10.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$98.55M(+157.9%) | -$27.92M(+29.4%) | -$98.55M(+17.4%) |
| Sep 2021 | - | -$21.58M(-25.2%) | -$83.94M(+16.1%) |
| Jun 2021 | - | -$28.84M(+42.7%) | -$72.32M(+41.1%) |
| Mar 2021 | - | -$20.21M(+51.8%) | -$51.27M(+34.2%) |
| Dec 2020 | -$38.21M(-1794.4%) | -$13.31M(+33.7%) | -$38.21M(+27.3%) |
| Sep 2020 | - | -$9.96M(+27.8%) | -$30.01M(+15.6%) |
| Jun 2020 | - | -$7.79M(+9.0%) | -$25.95M(+823.8%) |
| Mar 2020 | - | -$7.15M(+39.9%) | -$2.81M(-224.6%) |
| Dec 2019 | $2.25M(-123.2%) | -$5.11M(-13.4%) | $2.25M(-69.4%) |
| Sep 2019 | - | -$5.90M(-138.4%) | $7.37M(-44.5%) |
| Jun 2019 | - | $15.35M(-835.9%) | $13.26M(-735.9%) |
| Mar 2019 | - | -$2.09M | -$2.09M |
| Dec 2018 | -$9.70M | - | - |
FAQ
- What is Avidity Biosciences annual free cash flow?
- What is the all time high annual FCF for Avidity Biosciences?
- What is Avidity Biosciences annual FCF year-on-year change?
- What is Avidity Biosciences quarterly free cash flow?
- What is the all time high quarterly FCF for Avidity Biosciences?
- What is Avidity Biosciences quarterly FCF year-on-year change?
- What is Avidity Biosciences TTM free cash flow?
- What is the all time high TTM FCF for Avidity Biosciences?
- What is Avidity Biosciences TTM FCF year-on-year change?
What is Avidity Biosciences annual free cash flow?
The current annual FCF of RNA is -$307.94M
What is the all time high annual FCF for Avidity Biosciences?
Avidity Biosciences all-time high annual free cash flow is $2.25M
What is Avidity Biosciences annual FCF year-on-year change?
Over the past year, RNA annual free cash flow has changed by -$184.64M (-149.76%)
What is Avidity Biosciences quarterly free cash flow?
The current quarterly FCF of RNA is -$128.58M
What is the all time high quarterly FCF for Avidity Biosciences?
Avidity Biosciences all-time high quarterly free cash flow is $15.64M
What is Avidity Biosciences quarterly FCF year-on-year change?
Over the past year, RNA quarterly free cash flow has changed by -$57.29M (-80.35%)
What is Avidity Biosciences TTM free cash flow?
The current TTM FCF of RNA is -$365.22M
What is the all time high TTM FCF for Avidity Biosciences?
Avidity Biosciences all-time high TTM free cash flow is $13.26M
What is Avidity Biosciences TTM FCF year-on-year change?
Over the past year, RNA TTM free cash flow has changed by -$221.42M (-153.98%)